| Literature DB >> 18452828 |
Marcel Zwahlen1, Andrew Renehan, Matthias Egger.
Abstract
Meta-analysis, the statistical combination of results from several studies to produce a single estimate of a treatment effect or size of an association, continues to attract controversy. We illustrate and discuss the promises and limitations of meta-analysis. Meta-analysis of clinical trials can prevent delays in the introduction of effective treatments or lead to the timely identification of adverse effects. However, meta-analyses are liable to numerous biases, both at the level of the individual study and the selection of studies for inclusion in meta-analysis. The biases and confounding factors that threaten the validity of individual studies will also affect meta-analyses of observational studies. We argue that meta-analyses should only be performed within the framework of systematic reviews that have been prepared using methods that minimize bias and address the combinability of studies.Mesh:
Year: 2007 PMID: 18452828 DOI: 10.1016/j.urolonc.2006.12.001
Source DB: PubMed Journal: Urol Oncol ISSN: 1078-1439 Impact factor: 3.498